Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.

Small molecules that can selectively target cancer stem cells (CSCs) remain rare currently and exhibit no common structural features. Here we report a series of guaianolide sesquiterpene lactones (GSLs) and their derivatives that can selectively eradicate acute myelogenous leukemia (AML) stem or progenitor cells. Natural GSL compounds arglabin, an anticancer clinical drug, and micheliolide (MCL), are able to reduce the proportion of AML stem cells (CD34⁺CD38⁻) in primary AML cells. Targeting of AML stem cells is further confirmed by a sharp reduction of colony-forming units of primary AML cells upon MCL treatment. Moreover, DMAMCL, the dimethylamino Michael adduct of MCL, slowly releases MCL in plasma and in vivo and demonstrates remarkable therapeutic efficacy in the nonobese diabetic/severe combined immunodeficiency AML models. These findings indicate that GSL is an ample source for chemical agents against AML stem or progenitor cells and that GSL is potentially highly useful to explore anti-CSC approaches.

[1]  Jianping Lin,et al.  Biomimetic semisynthesis of arglabin from parthenolide. , 2012, The Journal of organic chemistry.

[2]  F. Leonetti,et al.  New strategies in the chemotherapy of leukemia: eradicating cancer stem cells in chronic myeloid leukemia. , 2012, Current cancer drug targets.

[3]  I. Merfort.  Perspectives on sesquiterpene lactones in inflammation and cancer. , 2011, Current drug targets.

[4]  H. Moch,et al.  Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. , 2011, Cancer research.

[5]  H. Abken,et al.  Eradication of melanomas by targeted elimination of a minor subset of tumor cells , 2011, Proceedings of the National Academy of Sciences.

[6]  S. Chakraborty,et al.  Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells , 2011, British Journal of Cancer.

[7]  H. Gali-Muhtasib,et al.  What made sesquiterpene lactones reach cancer clinical trials? , 2010, Drug discovery today.

[8]  Irving L. Weissman,et al.  Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271 , 2010, Nature.

[9]  Tao Zhang,et al.  Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells , 2010, Clinical Cancer Research.

[10]  K. Peese.  New agents for the treatment of leukemia: discovery of DMAPT (LC-1) , 2010 .

[11]  D. Birnbaum,et al.  CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. , 2010, The Journal of clinical investigation.

[12]  G. Koch,et al.  Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine. , 2009, Journal of medicinal chemistry.

[13]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[14]  P. Crooks,et al.  Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1). , 2009, Bioorganic & medicinal chemistry letters.

[15]  E. Hurt,et al.  Effects of the sesquiterpene lactone parthenolide on prostate tumor‐initiating cells: An integrated molecular profiling approach , 2009, The Prostate.

[16]  J. Downing,et al.  Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. , 2009, Blood.

[17]  S. Doublier,et al.  Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium‐dependent activation of HIF‐1α and P‐glycoprotein overexpression , 2009, British journal of pharmacology.

[18]  M. Dell’Agli,et al.  Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives. , 2009, Bioorganic & medicinal chemistry letters.

[19]  Sung-Tae Hong,et al.  Resistance of cholangiocarcinoma cells to parthenolide-induced apoptosis by the excretory–secretory products of Clonorchis sinensis , 2009, Parasitology Research.

[20]  Han-Ming Shen,et al.  NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy , 2009, Apoptosis.

[21]  S. Lang,et al.  Prostate cancer stem cells , 2009, The Journal of pathology.

[22]  Lawrence Lum,et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer , 2008, Nature chemical biology.

[23]  Hao Zhang,et al.  NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells , 2008, Breast Cancer Research and Treatment.

[24]  D. Stolz,et al.  A stochastic model for cancer stem cell origin in metastatic colon cancer. , 2008, Cancer research.

[25]  F. Bollmann.  The many faces of telomerase: emerging extratelomeric effects , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  Yang Liu,et al.  A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[27]  N. Maitland,et al.  Prostate cancer stem cells: a new target for therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Rich,et al.  Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Curt Balch,et al.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.

[30]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[31]  O. Reiser,et al.  Synthesis of Biologically Active Guaianolides with a trans-Annulated Lactone Moiety , 2008 .

[32]  M. Talpaz,et al.  Getting to the stem of chronic myeloid leukaemia , 2008, Nature Reviews Cancer.

[33]  L. Zon,et al.  Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.

[34]  I. Weissman,et al.  Stems Cells and the Pathways to Aging and Cancer , 2008, Cell.

[35]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[36]  M. Carroll,et al.  An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. , 2007, Blood.

[37]  L. Augsburger,et al.  The solution and solid state stability and excipient compatibility of parthenolide in feverfew , 2007, AAPS PharmSciTech.

[38]  H. Mitsuya,et al.  Acute Promyelocytic Leukemia Harboring STAT5b-RARα Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene. , 2007 .

[39]  R. Bandichhor,et al.  Enantioselective synthesis of arglabin. , 2007, Angewandte Chemie.

[40]  M. V. Van Dyke,et al.  Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated. , 2007, Chemistry & biology.

[41]  P. Schludermann,et al.  The Root of the Problem , 2007, Science.

[42]  W. Woodward,et al.  WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells , 2007, Proceedings of the National Academy of Sciences.

[43]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[44]  M. Diehn,et al.  Cancer stem cells and radiotherapy: new insights into tumor radioresistance. , 2006, Journal of the National Cancer Institute.

[45]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[46]  Alison Abbott,et al.  Cancer: The root of the problem , 2006, Nature.

[47]  B. Petersen,et al.  AUTOIMMUNE PANCREATITIS: DIAGNOSIS USING HISTOLOGY, IMAGING, SEROLOGY, OTHER ORGAN INVOLVEMENT AND RESPONSE TO STEROIDS , 2005 .

[48]  Derick R. Peterson,et al.  The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. , 2005, Blood.

[49]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[50]  C. Jordan.  Cancer stem cell biology: from leukemia to solid tumors. , 2004, Current opinion in cell biology.

[51]  David M. Berman,et al.  Tissue repair and stem cell renewal in carcinogenesis , 2004, Nature.

[52]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[53]  P. O’Neill,et al.  A medicinal chemistry perspective on artemisinin and related endoperoxides. , 2004, Journal of medicinal chemistry.

[54]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[56]  H. Neukirch,et al.  Parthenolide and its photochemically synthesized 1(10)Z isomer: chemical reactivity and structure-activity relationship studies in human leucocyte chemotaxis. , 2003, Bioorganic & medicinal chemistry.

[57]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  D. Howard,et al.  Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. , 2001, Blood.

[59]  A. Diévart,et al.  Involvement of Notch1 in the development of mouse mammary tumors , 1999, Oncogene.

[60]  R. Wallace.  High-throughput screening , 1998 .

[61]  K. Schulze-Osthoff,et al.  Sesquiterpene Lactones Specifically Inhibit Activation of NF-κB by Preventing the Degradation of IκB-α and IκB-β* , 1998, The Journal of Biological Chemistry.

[62]  O. Legrand,et al.  Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P‐glycoprotein over‐expression , 1998, British journal of haematology.

[63]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[64]  V. Kumar,et al.  Sesquiterpene lactones from Michelia champaca , 1995 .

[65]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[66]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[67]  S. Ruben,et al.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. , 1991, Science.

[68]  D. Baltimore,et al.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor , 1988, Cell.

[69]  S. Adekenov,et al.  Arglabin — A new sesquiterpene lactone fromArtemisia glabella , 1982, Chemistry of Natural Compounds.

[70]  H. Mo,et al.  Amino -derivatives of the sesquiterpene lactone class of natural products as prodrugs , 2013 .

[71]  Irving L. Weissman,et al.  Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 , 2011, Nature.

[72]  T. Shaikenov,et al.  Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase. , 2001, Oncology reports.

[73]  N. Fischer,et al.  Biomimetic transformations of parthenolide. , 1993, Journal of natural products.